Radiofrequency-induced thermo-chemotherapy effect plus mitomycin versus a second course of bacillus Calmette-Guérin (BCG) or institutional standard in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance BCG therapy (HYMN): A phase III, open-label, randomised controlled trial

Subjects

Subjects :

0301 basic medicine
medicine.medical_specialty
Bladder cancer
business.industry
Urology
Bcg therapy
Thermo chemotherapy
medicine.disease
Surgery
law.invention
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Randomized controlled trial
law
030220 oncology & carcinogenesis
medicine
In patient
Open label
business
Non muscle invasive

Details

ISSN :

15699056

Volume :

16

Database :

OpenAIRE

Journal :

European Urology Supplements

Accession number :

edsair.doi...........e703baceaac86c1d8c900d19e2ab12c9

Full Text :

https://doi.org/10.1016/s1569-9056(17)30720-0